Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99)
- 31 March 2002
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 42 (3), 193-198
- https://doi.org/10.1016/s0732-8893(01)00353-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Variations in the Prevalence of Strains Expressing an Extended‐Spectrum β‐Lactamase Phenotype and Characterization of Isolates from Europe, the Americas, and the Western Pacific RegionClinical Infectious Diseases, 2001
- A Novel Class A Extended-Spectrum β-Lactamase (BES-1) in Serratia marcescens Isolated in BrazilAntimicrobial Agents and Chemotherapy, 2000
- EXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMSInfectious Disease Clinics of North America, 1997
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- Plasmid-mediated production of Class I (AmpC) β-lactamase by two Klebsiella pneumoniae isolates from the UKJournal of Antimicrobial Chemotherapy, 1995
- -Lactamases of Gram-Negative Bacteria: New Challenges for New DrugsClinical Infectious Diseases, 1992
- A new plasmidic cefotaximase from patients infected withSalmonella typhimuriumInfection, 1992
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityAntimicrobial Agents and Chemotherapy, 1990
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- In Vivo Selection of a Cephamycin-Resistant, Porin-Deficient Mutant of Klebsiello pneumoniae Producing a TEM-3 -LactamaseThe Journal of Infectious Diseases, 1989